Navigation Links
Light technology to combat hospital infections
Date:11/15/2010

A pioneering lighting system that can kill hospital superbugs including MRSA and C.diff has been developed by researchers at the University of Strathclyde in Glasgow, Scotland.

The technology decontaminates the air and exposed surfaces by bathing them in a narrow spectrum of visible-light wavelengths, known as HINS-light.

Clinical trials at Glasgow Royal Infirmary have shown that the HINS-light Environmental Decontamination System provides significantly greater reductions of bacterial pathogens in the hospital environment than can be achieved by cleaning and disinfection alone, providing a huge step forward in hospitals' ability to prevent the spread of infection.

This novel decontamination technology was discovered and developed by a multidisciplinary team of experts, Professor Scott MacGregor (Electrical Engineer), Professor John Anderson and Dr Michelle Maclean (Microbiologists) and Professor Gerry Woolsey (Optical Physicist.)

Professor Anderson said: "The technology kills pathogens but is harmless to patients and staff, which means for the first time, hospitals can continuously disinfect wards and isolation rooms.

"The system works by using a narrow spectrum of visible-light wavelengths to excite molecules contained within bacteria. This in turn produces highly reactive chemical species that are lethal to bacteria such as meticillin-resistant Staphylococcus aureus, or MRSA, and Clostridium difficile, known as C.diff."

Dr Maclean added: "The clinical trials have shown that the technology can help prevent the environmental transmission of pathogens and thereby increase patient safety."

The technology uses HINS-light which has a violet hue, but the research team have used a combination of LED technologies to produce a warm white lighting system that can be used alongside normal hospital lighting.

Professor Scott MacGregor, Dean of the Faculty of Engineering, said: "New approaches to disinfection and sterilisation are urgently needed within the clinical environment, as traditional methods have significant limitations.

"Decontamination methods involving gas sterilants or UV-light can be hazardous to staff and patients, while cleaning, disinfection and hand washing, although essential routine procedures, have limited effectiveness and problems with compliance.

"HINS-light is a safe treatment that can be easily automated to provide continuous disinfection of wards and other areas of the clinical environment. The pervasive nature of light permits the treatment of air and all visible surfaces, regardless of accessibility, either through direct or reflected exposure to HINS-light within the treated environment."

The technology was developed in the University of Strathclyde's pioneering Robertson Trust Laboratory for Electronic Sterilisation Technologies (ROLEST), which is dedicated to controlling infection in today's healthcare environments.


'/>"/>

Contact: Kat Hannah
kat.hannah@strath.ac.uk
44-014-154-84123
University of Strathclyde
Source:Eurekalert

Related biology news :

1. October 2008 GEOLOGY and GSA TODAY media highlights
2. Agricultural research highlighted in Houston
3. Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
4. Can genetic information be controlled by light?
5. AGU journal highlights -- Oct. 16, 2008
6. Scripps research team sheds light on immune system suppression
7. Study sheds new light on dolphin coordination during predation
8. Spotlight on cosmetic ingredients conference
9. Polarized light guides cholera-carrying midges that contaminate water supplies
10. Study sheds light on genetic differences that cause a childhood eye disease
11. Hydrogen tank lighter than battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
Breaking Biology Technology: